Aliases & Classifications for Teratoma, Ovarian

MalaCards integrated aliases for Teratoma, Ovarian:

Name: Teratoma, Ovarian 56
Dermoid Cyst, Ovarian 56
Ovarian Teratoma 17

Characteristics:

OMIM:

56
Inheritance:
autosomal dominant


HPO:

31
teratoma, ovarian:
Inheritance autosomal dominant inheritance


External Ids:

OMIM 56 166950
MedGen 41 C0280131
SNOMED-CT via HPO 68 263681008 716077006

Summaries for Teratoma, Ovarian

MalaCards based summary : Teratoma, Ovarian, also known as dermoid cyst, ovarian, is related to ovarian cystic teratoma and ovarian germ cell teratoma. The drugs Cyclophosphamide and Captopril have been mentioned in the context of this disorder. Affiliated tissues include ovary, thyroid and bone, and related phenotype is ovarian teratoma.

More information from OMIM: 166950

Related Diseases for Teratoma, Ovarian

Diseases related to Teratoma, Ovarian via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 238)
# Related Disease Score Top Affiliating Genes
1 ovarian cystic teratoma 11.8
2 ovarian germ cell teratoma 11.7
3 dermoid cyst of ovary 11.6
4 ovarian solid teratoma 11.5
5 ovarian fetiform teratoma 11.3
6 immature teratoma of ovary 11.3
7 teratoma 10.7
8 struma ovarii 10.5
9 cystic teratoma 10.4
10 paraneoplastic limbic encephalitis 10.4
11 thyroid cancer, nonmedullary, 1 10.3
12 endometriosis 10.2
13 mature teratoma 10.2
14 neuroblastoma 10.2
15 squamous cell carcinoma 10.2
16 embryonal carcinoma 10.2
17 hemolytic anemia 10.2
18 mature teratoma of the ovary 10.2
19 adenoma 10.2
20 anemia, autoimmune hemolytic 10.1
21 ataxia and polyneuropathy, adult-onset 10.1
22 oligodendroglioma 10.1
23 choriocarcinoma 10.1
24 intestinal obstruction 10.1
25 encephalitis 10.1
26 rare tumor 10.1
27 ocular motor apraxia 10.1
28 wilms tumor 5 10.1
29 benign teratoma 10.1
30 respiratory failure 10.1
31 adenocarcinoma 10.1
32 mucinous adenocarcinoma 10.1
33 glioblastoma multiforme 10.1
34 cystadenocarcinoma 10.1
35 appendix adenocarcinoma 10.1
36 malignant struma ovarii 10.1
37 hyperthyroidism 10.1
38 appendicitis 10.1
39 47,xyy 10.1
40 opsoclonus-myoclonus syndrome 10.1
41 teratoma with malignant transformation 10.1
42 myoclonus 10.1
43 paraneoplastic syndromes 10.1
44 growing teratoma syndrome 10.1
45 breast cancer 10.0
46 medulloblastoma 10.0
47 nondisjunction 10.0
48 retinoblastoma 10.0
49 wilms tumor 1 10.0
50 hydatidiform mole, recurrent, 1 10.0

Graphical network of the top 20 diseases related to Teratoma, Ovarian:



Diseases related to Teratoma, Ovarian

Symptoms & Phenotypes for Teratoma, Ovarian

Human phenotypes related to Teratoma, Ovarian:

31
# Description HPO Frequency HPO Source Accession
1 ovarian teratoma 31 HP:0012226

Symptoms via clinical synopsis from OMIM:

56
G U:
ovarian teratoma

Clinical features from OMIM:

166950

Drugs & Therapeutics for Teratoma, Ovarian

Drugs for Teratoma, Ovarian (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 87)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cyclophosphamide Approved, Investigational Phase 3 50-18-0, 6055-19-2 2907
2
Captopril Approved Phase 3 62571-86-2 44093
3
Fluconazole Approved, Investigational Phase 3 86386-73-4 3365
4
Clotrimazole Approved, Vet_approved Phase 3 23593-75-1 2812
5
Miconazole Approved, Investigational, Vet_approved Phase 3 22916-47-8 4189
6
Itraconazole Approved, Investigational Phase 3 84625-61-6 55283
7
Ribavirin Approved Phase 3 36791-04-5 37542
8
Palivizumab Approved, Investigational Phase 3 188039-54-5
9
Amphotericin B Approved, Investigational Phase 3 1397-89-3 5280965 14956
10
Caspofungin Approved Phase 3 162808-62-0, 179463-17-3 2826718 468682
11 Alkylating Agents Phase 3
12 Immunologic Factors Phase 3
13 Antihypertensive Agents Phase 3
14 Immunosuppressive Agents Phase 3
15 Angiotensin-Converting Enzyme Inhibitors Phase 3
16 HIV Protease Inhibitors Phase 3
17
protease inhibitors Phase 3
18 Antirheumatic Agents Phase 3
19 Cytochrome P-450 Enzyme Inhibitors Phase 3
20 Anti-Infective Agents Phase 3
21 Hormone Antagonists Phase 3
22 Hormones Phase 3
23
Hydroxyitraconazole Phase 3
24 Antifungal Agents Phase 3
25 Cytochrome P-450 CYP3A Inhibitors Phase 3
26 Immunoglobulins Phase 3
27 Antibodies Phase 3
28 Antiviral Agents Phase 3
29 Antibodies, Monoclonal Phase 3
30 Antimetabolites Phase 3
31 Amebicides Phase 3
32 Antiparasitic Agents Phase 3
33 Anti-Bacterial Agents Phase 3
34 Antiprotozoal Agents Phase 3
35 Liposomal amphotericin B Phase 3
36
Paclitaxel Approved, Vet_approved Phase 2 33069-62-4 36314
37
Etoposide Approved Phase 2 33419-42-0 36462
38
Lenograstim Approved, Investigational Phase 2 135968-09-1
39
Ifosfamide Approved Phase 2 3778-73-2 3690
40
Carboplatin Approved Phase 2 41575-94-4 10339178 38904 498142
41
Cisplatin Approved Phase 2 15663-27-1 2767 441203 84093
42
Sunitinib Approved, Investigational Phase 2 557795-19-4, 341031-54-7 5329102
43
Oprelvekin Approved, Investigational Phase 2 145941-26-0
44
Sargramostim Approved, Investigational Phase 2 83869-56-1, 123774-72-1
45
Aldesleukin Approved Phase 2 85898-30-2, 110942-02-4
46
Vincristine Approved, Investigational Phase 2 57-22-7, 2068-78-2 5978
47
Levoleucovorin Approved, Investigational Phase 2 68538-85-2
48
Doxorubicin Approved, Investigational Phase 2 23214-92-8 31703
49
Methotrexate Approved Phase 2 59-05-2, 1959-05-2 126941
50
leucovorin Approved Phase 2 58-05-9 6006 143

Interventional clinical trials:

(show all 19)
# Name Status NCT ID Phase Drugs
1 Phase III Study of Captopril in Patients Undergoing Autologous Bone Marrow/Stem Cell Transplantation Completed NCT00004230 Phase 3 captopril;cyclophosphamide
2 A Randomized, Comparative Study of Itraconazole Versus Fluconazole for Prevention of Aspergillus Infections in Peripheral Blood Stem Cell and Marrow Transplant Recipients Completed NCT00003883 Phase 3 fluconazole;itraconazole
3 A Randomized Double-Blind Placebo-Controlled Phase III Study To Evaluate The Safety And Efficacy Of Palivizumab Combined With Aerosolized Ribavirin Compared To Ribavirin Alone To Treat RSV Pneumonia In Patients With Bone Marrow Transplants (BMT) Completed NCT00014391 Phase 3 ribavirin
4 A Strategic Study to Determine the Optimal Moment to Initiate Systemic Antifungal Therapy With Ambisome in Granulocytopenic Cancer Patients With Unexplained Fever Refractory to Empirical Antibacterials Completed NCT00003938 Phase 3 liposomal amphotericin B
5 A Multicenter, Double-Blind, Randomized, Comparative Study To Evaluate The Safety, Tolerability, And Efficacy Of MK-0991 Versus (Amphotericin B) Liposome For Injection As Empirical Therapy In Patients With Persistent Fever And Neutropenia Completed NCT00008359 Phase 3 caspofungin acetate;liposomal amphotericin B
6 A PHASE II STUDY OF CELLULAR ADOPTIVE IMMUNOTHERAPY AS PROPHYLAXIS FOR CYTOMEGALOVIRUS DISEASE AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION Completed NCT00002673 Phase 2
7 Tandem High-Dose Chemotherapy With Autologous Stem Cell Rescue for Poor-Prognosis Germ Cell Cancer Completed NCT00002931 Phase 2 carboplatin;etoposide;ifosfamide;paclitaxel
8 Phase II Trial of Paclitaxel, Ifosfamide, and Cisplatin in Previously Untreated Intermediate and Poor Risk Germ Cell Tumor Patients Completed NCT00470366 Phase 2 cisplatin;ifosfamide;paclitaxel
9 A Phase II Study of Sunitinib in Patients With Refractory or Relapsed Germ Cell Tumors Completed NCT00453310 Phase 2 sunitinib malate
10 Combination of Interleukin 11 (Neumega) With G-CSF to Mobilize Autologous Peripheral Blood Stem Cells (PBSC) Completed NCT00004157 Phase 2
11 Donor Lymphocyte Infusion (DLI) as Adoptive Immunotherapy for Relapse Malignancies After Allogeneic Hematopoietic Transplantation Completed NCT00003887 Phase 2
12 Oral Beclomethasone Dipropionate Capsules for Treatment of Intestinal Graft-Versus-Host Disease: Compassionate Use in Patients With Contraindictions to High-Dose Immunosuppressive Therapy Completed NCT00010283 Phase 1, Phase 2 beclomethasone dipropionate
13 Cytokine-Based Immunotherapy Following High-Dose Chemotherapy and Autologous Stem Cell Transplantation Completed NCT00003408 Phase 2
14 PROTOCOL FOR THE TREATMENT OF MALIGNANT NON-TESTICULAR GERM CELL TUMORS Completed NCT00002489 Phase 2 carboplatin;cyclophosphamide;doxorubicin hydrochloride;etoposide;leucovorin calcium;methotrexate;vincristine sulfate
15 A Phase I Trial of Recombinant Human Interleukin-12 After High-Dose Therapy and Autologous Hematopoietic Stem Cell Support Completed NCT00003107 Phase 1
16 A Randomized, Placebo-Controlled, Blinded Study Of Acupuncture Therapy In Mucositis-Related Pain In Patients Undergoing Hematopoietic Stem Cell Transplantation Completed NCT00060021
17 Multi-Site Randomized Clinical Trial Comparing Standard Recovery Preparation to Extended Recovery Preparation to Enhance Long Term Function After Marrow or Stem Cell Transplant Completed NCT00049465
18 MOLecular Characterization and Treatment of THYroid Carcinoma on Struma Ovarii Not yet recruiting NCT04053114
19 Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Study of Nab-Paclitaxel (Nanoparticle Albumin Bound-Paclitaxel) in Patients With Advanced Solid Tumors Withdrawn NCT00499291 paclitaxel albumin-stabilized nanoparticle formulation

Search NIH Clinical Center for Teratoma, Ovarian

Genetic Tests for Teratoma, Ovarian

Anatomical Context for Teratoma, Ovarian

MalaCards organs/tissues related to Teratoma, Ovarian:

40
Ovary, Thyroid, Bone, Bone Marrow, Brain, Liver, Lung

Publications for Teratoma, Ovarian

Articles related to Teratoma, Ovarian:

(show top 50) (show all 1028)
# Title Authors PMID Year
1
Familial occurrence of mature ovarian teratomas. 56
4022488 1985
2
The origin of ovarian teratomas. 56
6363699 1984
3
Ovarian teratomas and genetics of germ-cell formation. 56
63792 1976
4
Parthenogenic origin of benign ovarian teratomas. 56
162806 1975
5
The development of teratomas from parthenogenetically activated ovarian mouse eggs. 56
4826282 1974
6
Familial incidence of ovarian dermoid cysts. 56
4707237 1973
7
BRAF Wild-type, PTEN Mutant Malignant Uveal Melanoma Arising Within a Mature Ovarian Teratoma: A Case Report and Review of the Literature. 61
31157687 2020
8
Single-cell transcriptional profiling identifies a cluster of potential metastasis-associated UBE2C+ cells in immature ovarian teratoma. 61
32505346 2020
9
Fetal Glomeruli in a Mature Ovarian Teratoma: A Developmental Anomaly Within a Developmental Anomaly? 61
31558071 2020
10
A Hairbrained Mature Cystic Ovarian Teratoma: With Bone Marrow, Meninges, and Intraglial Hair. 61
32489128 2020
11
Anti-N-methyl-D-aspartate Receptor Encephalitis: a Rare Complication of Ovarian Teratoma. 61
32567259 2020
12
Anti-NMDA receptor encephalitis associated with ovarian tumor: the gynecologist point of view. 61
32556515 2020
13
Ultrasound features of immature ovarian teratomas: Case series and review of literature. 61
32528544 2020
14
Clinical significance of Kelch-like protein 11 antibodies. 61
31953318 2020
15
Commentary on "Psychosis associated to CASPR2 autoantibodies and ovarian teratoma: A case report". 61
32505929 2020
16
Psychiatric Presentation of Probable Seronegative Autoimmune Encephalitis in a Late Middle-Aged Woman With Ovarian Teratoma. 61
31607502 2020
17
Coexistence of endometriosis in women with mature cystic ovarian teratoma may not be rare. 61
32413526 2020
18
Role of staging surgery and adjuvant chemotherapy in adult patients with apparent stage I pure immature ovarian teratoma after fertility-sparing surgery. 61
32179695 2020
19
Mature cystic ovarian teratoma without intracystic fat: Case report with the "fat within the wall" sign. 61
32055261 2020
20
Pediatric whole body MRI detects causative ovarian teratoma in opsoclonus myoclonus syndrome. 61
31890069 2020
21
Psychosis associated to CASPR2 autoantibodies and ovarian teratoma: A case report. 61
31848022 2020
22
What recent primary studies tell us about ovarian teratomas in children: a scoping review. 61
32006216 2020
23
Age-Dependent Presentation and Clinical Course of 1465 Patients Aged 0 to Less than 18 Years with Ovarian or Testicular Germ Cell Tumors; Data of the MAKEI 96 Protocol Revisited in the Light of Prenatal Germ Cell Biology. 61
32155835 2020
24
Generation of human androgenetic induced pluripotent stem cells. 61
32109236 2020
25
Malignant struma ovarii with a robust response to radioactive iodine. 61
32061155 2020
26
Incidence of anti-NMDAR encephalitis in patients undergoing resection of ovarian teratoma in a single institution. 61
31846782 2020
27
Anti-N-methyl-D-aspartate receptor encephalitis with accompanying ovarian teratoma in female patients from East China: Clinical features, treatment, and prognostic outcomes. 61
31874360 2020
28
High-grade glioma arising in immature ovarian teratoma. 61
32108640 2020
29
Mature Ovarian Teratoma: Atypical Imaging. 61
32148993 2020
30
Anti-NMDAR encephalitis: A single-center, longitudinal study in China. 61
31619447 2020
31
Laparoscopic Ovarian Dermoid Cystectomy in 10 Steps. 61
31125721 2020
32
Collision Glial Neoplasms Arising in an Ovarian Mature Cystic Teratoma: A Rare Event. 61
32082676 2020
33
Case report: meningitis as a presenting feature of anti-NMDA receptor encephalitis. 61
31910823 2020
34
Considerations of psychotic symptomatology in anti-NMDA encephalitis: Similarity to cycloid psychosis. 61
31893079 2019
35
[Clinical symptoms of patients with autoimmune encephalitis: a guide to timely recognition and treatment]. 61
32073782 2019
36
Ruptured ovarian teratoma with granulomatous peritonitis. 61
32127503 2019
37
Treatment of Anti-NMDA Receptor Encephalitis with Ovarian Teratoma Removal: A Literature Review and Two Case Reports. 61
32215098 2019
38
Vaginal Teratoma: A Fistulized or Parasitic Recurrent Ovarian Teratoma? A Case Report. 61
30831278 2019
39
An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. 61
31326280 2019
40
Surgical outcomes in patients with anti-N-methyl D-aspartate receptor encephalitis with ovarian teratoma. 61
31128109 2019
41
Anti-N-methyl-D-aspartate receptor encephalitis induced by bilateral ovarian teratomas with distinct histopathologic types: A case report and brief literature review. 61
31770255 2019
42
Pre-existing medical disorders as risk factors for preeclampsia: an exploratory case-control study. 61
31530202 2019
43
Normal gut microbiome in NMDA receptor encephalitis. 61
31624178 2019
44
Comparative RNA-seq analysis aids in diagnosis of a rare pediatric tumor. 61
31645344 2019
45
Encephalitis on deployment in Kenya: think beyond the infections. 61
30992337 2019
46
Clinical approach to the diagnosis and successful management of anti-NMDA receptor encephalitis when antibody testing is not possible. 61
31604715 2019
47
Rare Case of Sarcomatoid Squamous Cell Carcinoma Arising in an Ovarian Mature Teratoma. 61
31658491 2019
48
[Multiple Primary Pulmonary Meningiomas]. 61
31506409 2019
49
The diffuse involvement of anti-N-methyl-D-aspartate receptor encephalitis in brain: a case report. 61
31558152 2019
50
Expression of SMAD4 is Retained in Most Gynecologic Tumors with Mucinous Differentiation. 61
31569186 2019

Variations for Teratoma, Ovarian

Expression for Teratoma, Ovarian

Search GEO for disease gene expression data for Teratoma, Ovarian.

Pathways for Teratoma, Ovarian

GO Terms for Teratoma, Ovarian

Sources for Teratoma, Ovarian

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....